ZFP57
protein-codingZFP57 zinc finger protein, the group of Zinc fingers C2H2-type
Gene summary
The protein encoded by this gene is a zinc finger protein containing a KRAB domain. Studies in mouse suggest that this protein may function as a transcriptional repressor. Mutations in this gene have been associated with transient neonatal diabetes mellitus type 1 (TNDM1).[provided by RefSeq, Sep 2009]
- C6orf40
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~8.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0011073
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0011073
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0011073
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0020525
Submitter: Genomics England PanelApp
Inheritance Pattern: AD
Disease ID:MONDO:0020525
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0011073
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0011073
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Endocrine
Intervention: Endocrine
Rationale: Individuals present early in life with failure to thrive, hyperglycemia, and dehydration, and prompt recognition and treatment can reduce morbidity
Comments: The pathogenesis can involve imprinting defects (eg, paternal UPD, paternal duplication, methylation defects)
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ZFP57 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001109809.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 22 | 26 | |||
| missense | 4 | 1 | 86 | 15 | 3 | 109 |
| nonsense | 1 | 1 | 1 | 3 | ||
| start loss | 0 | |||||
| frameshift | 6 | 2 | 8 | |||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 11 | 4 | 91 | 37 | 3 | 146 |
Highest pathogenic variant AF is 0.000010540557
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001103279.2 | 4 | MANE Select | |
| Ensembl | ENSP00000366080.2 | 4 | MANE Select | |
| RefSeq | NP_001353262.1 | 3 | Standard | |
| Ensembl | ENSP00000418259.2 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- regulation of gene expression by genetic imprinting
- regulation of transcription by RNA polymerase II
- DNA methylation involved in embryo development
Molecular Function
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA binding
- metal ion binding
Cellular Component
- nucleus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000488757
- Coding exons
- 4
- Length
- 8719
- Individuals with no LoFs
- 124811
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 9
- Defined
- 124820
- p
- 0.0000361
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.38 | 219 | 285 | 0.770 | 0.0000152 | 3556 |
| Missense (PolyPhen) | 45 | 70.997 | 0.63383 | 944 | ||
| Synonymous | 1.21 | 92 | 108 | 0.852 | 0.00000561 | 1012 |
| Loss of Function | 0.876 | 6 | 8.81 | 0.681 | 3.80e-7 | 105 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00028 | 0.00026 | rare |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0.000066 | 0.000065 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Binds to a 5'-TGCCGC-3' consensus sequence and recognizes the methylated CpG within this element (By similarity). Transcription regulator required to maintain maternal and paternal gene imprinting, a process by which gene expression is restricted in a parent of origin-specific manner by epigenetic modification of genomic DNA and chromatin, including DNA methylation. Acts by controlling DNA methylation during the earliest multicellular stages of development at multiple imprinting control regions. Required for the establishment of maternal methylation imprints at SNRPN locus. Acts as a transcriptional repressor in Schwann cells. {ECO:0000250, ECO:0000269|PubMed:18622393}.;
- Disease
- DISEASE: Transient neonatal diabetes mellitus 1 (TNDM1) [MIM:601410]: Neonatal diabetes is a form of diabetes mellitus defined by the onset of mild-to-severe hyperglycemia within the first months of life. In about half of the neonates, diabetes is transient and resolves at a median age of 3 months, whereas the rest have a permanent form of diabetes. {ECO:0000269|PubMed:18622393}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- LoFtool
- 0.716
- RVIS EVS
- 1.97
- RVIS percentile EVS
- 97.58
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.00277
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |